zantriocom's Blog : Zantrio.com Free Daily Stock Picks 11-9-09

November 9, 2009

Comments (0) Rate this post

Recommend This Post (59) Abuse this post

Report Abuse

Share This

(TRGT) - buy
Targacept saw a gain during post-market trading of over 6% - could something be in the wind to make share price move higher as it nears its current 52 week high?

(EXEL) - buy
Exelixis, working with some of the largest in the pharm indtry such as GlaxoSmithKline, Bristol-Myers Squibb, Sanofi-Aventis and Roche/Genentech - could EXEL be the next takeover target?

(CBY) - buy
Kraft in the midst of hostile takeover of Cadbury?

(PCLN) - buy
Priceline is set to report earnings of $2.90 per share - odds say they could report in range and provide positive guidance.

(FLR) - short
Fluor is projected to report Q3 earnings of 90 cents p/s - watch out below if it misses or guides lower.

(LYV) - short
Live Nation scheduled to report earnings of 88 cents p/s, failing to please the street could mean down time for shares.

-------

Signup and get instant entry alerts for the Free Daily Stock Picks at Zantrio.com

Tags : TRGT EXEL CBY PCLN FLR LYV

Want to comment on this post? Sign up now. It's FREE!
Already registered? Log In.

Sponsored Links

Take advantage of quick short-term moves, and profit from price moves in any direction. Trade options under the direction of an expert guide. Try it now and get a 90-day unconditional money-back guarantee. 50% OFF for a limited time! Zacks Options Trader >>

Make Big Bucks promoting Zacks products on your website! Click here to Learn about Zacks' Affiliate program.

Zacks Top Ten Stocks for 2011 are now available! This 10-stock portfolio is a well-balanced mix of aggressive and conservative, large and small cap, growth and value. Buy them. Hold them. Watch your gains add up

No Stocks are Harder to Find, or More Worth the Effort.
They have the greatest potential for quick gains, but they're also the most difficult to find and time correctly. Now Zacks has perfected a system for identifying and profiting from turnaround stocks just as they begin a powerful rebound. Learn more here >>.